EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Clinical Features and Outcomes of Infections Caused by Metallo-β-Lactamase–Producing Enterobacterales: A 3-Year Prospective Study From an Endemic Area

Marco Falcone iD, Cesira Giordano, Alessandro Leonildi, Valentina Galfo, Aurelio Lepore, Lorenzo Roberto Suardi, Niccolò Riccardi, Simona Barnini, Giusy Tiseo iD

Clinical Infectious Diseases · 15.05.2024 · 78 (5) · 1111-1119

DOI: 10.1093/cid/ciad725 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 30.11.2023. Verfasst von Marco Falcone und 8 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: beta-Lactamases, Enterobacteriaceae Infections, Anti-Bacterial Agents, Enterobacteriaceae. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metallo-β-lactamase (MBL)–producing Enterobacterales are increasing worldwide. Our aim was to describe clinical features, treatments, and outcomes of infections by MBL-Enterobacterales.

Methods

A prospective observational study conducted in the Pisa University Hospital (January 2019 to October 2022) included patients with MBL-producing Enterobacterales infections. The primary outcome measure was the 30-day mortality rate. Multivariable Cox regression analysis was performed to identify factors associated with that mortality rate, and adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) were calculated.

Results

The study’s 343 patients included 15 with Verona integron-encoded MBL (VIM)- and 328 with New Delhi MBL (NDM)–producing Enterobacterales infections; there were 199 patients (58%) with bloodstream infections, 60 (17.5%) with hospital-acquired or ventilator-associated pneumonia, 60 (17.5%) with complicated urinary tract infections, 13 (3.8%) with intra-abdominal infections, and 11 (3.2%) with skin and soft-tissue infections. The 30-day mortality rate was 29.7%. Of 343 patients, 32 did not receive in vitro active antibiotic therapy, 215 (62.7%) received ceftazidime-avibactam plus aztreonam, 33 (9.6%) received cefiderocol-containing regimens, 26 (7.6%) received colistin-containing regimens, and 37 (10.8%) received other active antibiotics. On multivariable analysis, septic shock (aHR, 3.57 [95% CI, 2.05–6.23]; P < .001) and age (1.05 [1.03–1.08]; P < .001) were independently associated with the 30-day mortality rate, while in vitro active antibiotic therapy within 48 hours after infection (0.48 [.26–.8]; P = .007) and source control (0.43 [.26–.72]; P = .001) were protective factors. Sensitivity analysis showed that ceftazidime-avibactam plus aztreonam, compared with colistin, was independently associated with a reduced 30-day mortality rate (aHR, 0.39 [95% CI, .18–.86]; P = .02). Propensity score analyses confirmed these findings.

Conclusions

MBL-producing carbapenem-resistant Enterobacterales infections are associated with high 30-day mortality rates. Patients with MBL-producing Enterobacterales infections should receive early active antibiotic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesEnterobacteriaceae InfectionsAnti-Bacterial AgentsEnterobacteriaceaeHumansMaleProspective StudiesFemaleMiddle AgedAgedAdultCeftazidimeAged, 80 and overMicrobial Sensitivity TestsDrug Resistance, Multiple, BacterialEndemic DiseasesDrug Combinations

Stichwörter der Autor:innen

Klebsiella pneumoniaeEnterobacteralesaztreonammetallo-β-lactamase

Substanzen

beta-LactamasesAnti-Bacterial AgentsCeftazidimeDrug Combinations

Autor:innen und Institutionen

  • Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy.
  • Microbiology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

ORCID-Profile: Marco Falcone, Giusy Tiseo

Zitieren

APA

Falcone, M., Giordano, C., Leonildi, A., Galfo, V., Lepore, A., Suardi, L. R., Riccardi, N., Barnini, S., & Tiseo, G. (2024). Clinical Features and Outcomes of Infections Caused by Metallo-β-Lactamase–Producing Enterobacterales: A 3-Year Prospective Study From an Endemic Area. Clinical Infectious Diseases, 78(5), 1111-1119. https://doi.org/10.1093/cid/ciad725

Vancouver

Falcone M, Giordano C, Leonildi A, Galfo V, Lepore A, Suardi LR, et al. Clinical Features and Outcomes of Infections Caused by Metallo-β-Lactamase–Producing Enterobacterales: A 3-Year Prospective Study From an Endemic Area. Clinical Infectious Diseases. 2024;78(5):1111-1119. doi:10.1093/cid/ciad725

BibTeX
@article{Falcone2024,
  author = {Falcone, Marco and Giordano, Cesira and Leonildi, Alessandro and Galfo, Valentina and Lepore, Aurelio and Suardi, Lorenzo Roberto and Riccardi, Niccolò and Barnini, Simona and Tiseo, Giusy},
  title = {Clinical Features and Outcomes of Infections Caused by Metallo-β-Lactamase–Producing Enterobacterales: A 3-Year Prospective Study From an Endemic Area},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {78},
  number = {5},
  pages = {1111--1119},
  doi = {10.1093/cid/ciad725}
}
Kostenlos starten →